Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Nightlife Industry Joins Covid-19 Vaccine Push for Young People
Leading figures of the nightlife industry – including venues Ministry of Sound and Heaven – […]
Eyevensys Raises $12M in a Series B Plus Funding Round
Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today […]
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 Million Doses of COVID-19 Vaccine
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today […]
Healthcare Experts Say Long COVID Threat Means the Virus ‘Isn’t Done With Us Yet’
Medical experts fear long term fallout from being infected by COVID-19 could be even more […]
NHS COVID-19 App Updated to Notify Fewer Contacts to Isolate
The public is being urged to continue to use the NHS COVID-19 app as changes […]
Micronoma Wins Bio-IT World Innovative Practices Award
Micronoma, the first cancer detection biotech company to diagnose cancer at an early stage with microbiome-driven […]
eTheRNA Immunotherapies Opens Office in Hong Kong to Support and Build on its Growing Activities in China and Broader Asia-Pacific
eTheRNA immunotherapies NV (‘eTheRNA’ or the ‘Company’), a clinical-stage company developing mRNA-based immunotherapies for the […]
New Tool for Early Identification of COVID-19 Surges
Health systems could use data from routine clinical care to identify the onset of upcoming […]
FDA Clears NYU Langone Genome PACT
The U.S. Food and Drug Administration (FDA) has cleared for clinical lab use a gene […]
Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more